Colmatek


Stopping severe bleeding is crucial in trauma, war, and surgery. We being scientists and experts in biotech have developed a new hemostatic agent that outperforms current options. It not only stops bleeding effectively but also promotes wound healing. After extensive lab tests and pre-clinical trials, we've launched ColMatEk to bring this patented technology to the market.

Industries

biotechnology
health-care
medical-device

Nr. of Employees

small (1-50)

Colmatek


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.